Clinical Trial Update: Magnesium Supplementation for the Prevention of Supraventricular Arrhythmias [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating magnesium supplementation for prevention of supraventricular arrhythmias in patients with premature atrial contractions; study complete…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Premature Atrial Contraction
• Supraventricular Arrhythmia

Drugs mentioned

• Magnesium supplementation (magnesium)

Snippet

Sponsor: University of Minnesota | Conditions: Premature Atrial Contraction | Phase 2 | Status: COMPLETED | Results posted: 2019-04-30